Peer Review History
| Original SubmissionNovember 25, 2020 |
|---|
|
PONE-D-20-35664 Common data elements for predictors of pediatric sepsis: A framework to standardize data collection PLOS ONE Dear Dr. Mawji, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 16 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Valérie Pittet, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. 3. Please provide additional details regarding participant consent to collect personal data, including email addresses, names, or phone numbers. In the Methods section, please ensure that you have specified how consent was obtained and how the study met relevant personal data and privacy laws. If data were collected anonymously, please include this information. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: [AC is supported by a Wellcome Trust Doctoral Training Fellowship. SA was supported by the Initiative to Develop African Research Leaders (IDeAL) Wellcome Trust award (# 107769).] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [The authors received no specific funding for this work.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [Figure 1 (the systematic review process) was also published in our related manuscript. It is not dual publication because are just using the results of a literature review we conducted in the previous publication for a new purpose. This is further detailed in the cover letter. ] Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. 6. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure. 7. Please include captions for ALL your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The article presents a collection of predictors of pediatric sepsis sepsis and describes the process how this set was selected. The selection is based on expert’s opinions, not analysing data. The aim is to make the selected data elements as a standardised way to collect pediatric sepsis data. This would increase compatibility across different studies on the topic. The topic of the study is definitely important and results have a clear impact. The research methodology is based on systematic literature review and domain experts’ knowledge through Delphi method. Finally, 116 data elements were accepted. The methodology is very well described and suitable for the study. However, the article does not describe whether any data collection has already done. Even a limited evaluation by using existing data would clearly improve the study. Naturally, predictive power of the data items is difficult to measure since it would require a large amount of data and it also depends on the research questions at hand. If any data is already available, some data quality measures could have been computed. These measures could include basic descriptive statistics such as the number of observations per patient, missing values, correlations, and distributions. This statistical validation could have been an additional step in used methodology but it would also be an additional validation step for the defined set of data items. The manuscript mentions that the aim is to facilitate the design of efficient data collections tools. Could you explain better what kind of tools these could be? In Conclusion, risk prediction tools are also mentioned. Are these two different sets of tools? Other comments: -Two tables S2 and S3 have the same title “Common data elements for predictors of pediatric sepsis: A framework to standardize data collection” -On these tables a reason for exclusion can be “low perceived predictive values”. Is also based only on expert’s opinions or statistical analysis? Reviewer #2: This is a very well written and important manuscript. The concept is well-defined and explained in the paper. There are some areas of redundancy that I think can be improved on (discussed more below). Abstract: - I really like how the amount of time and material resources to reliably collect the predictor in resource-limited settings was considered -- this is extremely important. - Conclusion line 72: replace "remains" with "remain" Introduction: - Lines 102 and 103: Please standardize how you present "data-driven" vs "data driven", as you spell it with and without a hyphen. - Line 105: Specify which settings you are referring to here. Low-resource settings? - Line 106: Improving healthcare delivery seems vague here compared to the following two examples of timely treatment and early referral. Perhaps clarify a bit or omit. - Line 113: Consider adding a source here. - Lines 121-123: Use of commas is confusing here, and it ends up being a run-on sentence. I would use ";" to help organize this sentence. - Line 125: For those unfamiliar with the PS2, I would suggest adding "a subgroup within the Pediatric Sepsis CoLab" after workgroup here. I know you go into more detail in the methods, but I would at least add that here in the Intro. - Last paragraph: Clarify what the objective of this current paper is. Is it the first sentence? I would suggest making this more clear by stating "the objective of this study" or something like that. Methods: - Objective section: This seems a bit repetitive with the objective paragraph in the Intro. Perhaps include this there, instead, and cut where redundant? - Line 173: Please keep past/present tense consistent throughout as past tense. Here please say "may have yielded". - Line 174: Also, keep in either active or passive voice. This whole paragraph is in passive voice but the last sentence switches to active voice. - Lines 188-190: Consider here the use of ";" rather than "," as otherwise this sentence is hard to follow. - Lines 231-232: For those unfamiliar with the Delphi method, perhaps clarify what "80% threshold required for consensus". Does that mean that 80% of experts had to agree that it was important enough to be included? - IRB approval was not discussed and should be included. - If possible to add in a little bit about the experts, like what countries they represent, that would be very interesting. Results: - Line 277: Missing a "(" in front of S2 Table. - Line 279-280: Most common reasons for exclusion "were". - Line 282: Please standardize spacing before and after "=" as you include spacing here but not elsewhere. - Lines 331-332: Although I understand the concept of branching logic being maximally harnessed by using electronic data collection, in many low-resource settings this is not a possibility. Is it also appropriate to do this on traditional paper methods? - Notes section: I might consider moving this to where you discuss Table 2 as otherwise the reader is jumping around quite a bit. - Standard operating protocols section: This seems a little out of place. I would either cut or elaborate beyond one simple sentence. Perhaps add an example to make this section more relevant and robust. - Feedback survey: How are the suggestions on the survey incorporated into the common data element set? Are they incorporated immediately or at certain time points? Are the just added in or does consensus have to be achieved on discussion? Perhaps provide some details on this here. - I may have missed this, but where is the list of the 116 predictors? Perhaps be more clear about where to find these. Discussion: - Summary paragraph: This is well written, but it is overall restating a lot of what you have stated above already. I would try to reduce redundancy and streamline a bit if possible here. - Adoption and use: This paragraph is in future tense, but shouldn't it be past tense since you have already done this? Also, a lot of these 2 paragraphs should go above in the results rather than the discussion. A lot of it is redundant and elaborating on logistics of accessing the Dataverse, so I would say include above where you talk about Dataverse. Conclusion: - Final sentence lines 441-444: Instead of saying "This was with the intent..." consider something like "This will enable collaboration", which looks towards the future and proves the benefit of the study. Reviewer #3: This is well-written and appropriately describes the Delphi process used. The expert consensus group is internationally representative, but is small in number (6 experts). I have no major concerns. Table 1 is confusing - it might be more helpful to include a sample with variables included, and to describe the significance of bolding and colors in the footnotes. Tables 2 and 3 are more clear. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Tapio Niemi Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Common data elements for predictors of pediatric sepsis: A framework to standardize data collection PONE-D-20-35664R1 Dear Dr. Mawji, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Valérie Pittet, PhD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All my comments and suggestions have been taken into account. I have no further concerns and I am happy to recommend the manuscript to be published in Plos One. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-20-35664R1 Common data elements for predictors of pediatric sepsis: A framework to standardize data collection Dear Dr. Mawji: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of PD Dr. Valérie Pittet Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .